Indivior Applies for Approval in Treating Opioid Abuse in U.S.

British pharmaceutical leader Indivior Plc announced this week its new drug application (NDA) to the U.S. Food and Drug Administration for its drug treating opioid use disorder (OUD). The drug, RBD-6000 acts as a monthly injectable opioid which in conjunction with...

Republic of Congo Announces Ebola Outbreak, Partners with Merck

The Democratic Republic of Congo’s health ministry has approved the use of a not-yet-licensed Merck vaccine to combat an outbreak of Ebola in the northeast which has killed four people. Clinical trials of the vaccine, rVSV-ZEBOV, last December showed a strong...

Maryland Passes Bill Banning Antibiotic Use in Meat Industry

The Maryland state senate passed a bill this week which is aimed at lowering the amount of “superbugs” transmitted through the meat and dairy industry. The bill, entitled Keep Antibiotics Effective Act, will become effective in October of this year following Governor...

Non Stimulant Found Successful in ADHD Treatment

NLS Pharma AG announced this week successful results of its ADHD clinical trial using Mazindol, a non-stimulant. The adult-focused study found that while the drug is not a traditional stimulant treatment of adult attention deficit hyperactive disorder (ADHD),...

Sodium Bicarbonate Shortage Postpones Hospital Treatments

Hospitals around the country have begun postponing treatments in the wake of a sodium bicarbonate shortage. The simple compound is used for patients whose blood has a higher acidity during surgical procedures, chemotherapy, and other vital treatments. Though drug...